Ensign Peak Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-317	Closed	-$58K	–	2255
2022 Q3	$58K	Buy	317 +67	+27%	+$12.3K	﹤0.01%	2196
2022 Q2	$22K	Hold	250	–	–	﹤0.01%	2124
2022 Q1	$39K	Hold	250	–	–	﹤0.01%	2149
2021 Q4	$74K	Buy	+250	New	+$74K	﹤0.01%	2106